Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy Vedran Cesarec Tomislav Becejac Marija Misic Zeljko Djakovic Danijela Olujic Domagoj Drmic Luka Brcic Dinko Stancic Rokotov Sven Seiwerth Predrag Sikiric ABSTRACT Esophagocutaneous fistulas are a failure of the NO-system, due to NO-synthase blockage by the NOS-blocker L-NAME consequently counteracted by l-arginine and gastric pentadecapeptide BPC 157 (l-arginine
Five months later, those numbers tell a story my bathroom mirror was already hinting at
The authors concluded that supplementation of HA to collagen did not improve various skin parameters, and therefore, the dermal benefits of the HA active ingredient could not be confirmed in this study [53]
Un secondo meccanismo riguarda le cellule staminali cutanee
Intracellular neutralisation of rotavirus by VP6-specific IgG
In rats given BPC-157, serotonin levels in the brain increase in specific regions while simultaneously decreasing in other regions, such as the hippocampus.[ref] A 2020 study found that BPC-157 reduced leaky gut syndrome by stabilizing gut permeability after NSAID use.[ref] Reducing leaky gut theoretically can affect the gut-brain axis and reduce inflammation
